Moreover, COVID‐19 ARDS is associated with proinflammatory lipid mediators including prostaglandin D2 (PGD2) (Archambault et al., 2021), which produces IL‐13 and is associated with respiratory failure (Ogletree et al., 2022). Here, IL13 is linked to respiratory failure.